Skip to content
BPL027BPL027BPL027

Drawing based on the label description. No photo yet.

“Flecainide acetate tablets, USP 150 mg tablets are color white, scored on one side and debossed with "BPL027" on the other side”

BPL027 pill

Pill with imprint BPL027 is white, capsule, 14 mm and has been identified as Flecainide Acetate 150 mg. It is used for atrial fibrillation (irregular heartbeat), fast heartbeat (SVT) and dangerous fast heartbeat. It is supplied by Bryant Ranch Prepack.

Flecainide Acetate 150 mg

Imprint
BPL027
Strength
150 mg
Used for
Atrial fibrillation (irregular heartbeat), fast heartbeat (SVT) and dangerous fast heartbeat
Color
White
Shape
Capsule / oblong
Size
14 mm
Score
Breaks into 2 pieces
Form
Tablet
Manufacturer
Bryant Ranch Prepack
Drug class
Heart rhythm medicine
NDC
71335-2655, 76385-147, 71335-2655-1, 71335-2655-2, 71335-2655-3, 71335-2655-4, 76385-147-60, 76385-147-01, 72789-384, 72789-384-60, 72789-384-01, 72789-384-93

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Flecainide Acetate pills and guides

What is Flecainide Acetate used for?

Flecainide Acetate is used for atrial fibrillation (irregular heartbeat), fast heartbeat (SVT) and dangerous fast heartbeat.

Medicine type
Heart rhythm medicine
Official uses from the US prescribing label

In patients without structural heart disease, flecainide is indicated for the prevention of

- paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms

- paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms.

Flecainide is also indicated for the prevention of

- documented ventricular arrhythmias, such as sustained ventricular tachycardia (sustained VT), that in the judgment of the physician, are life-threatening.

Use of flecainide for the treatment of sustained VT, like other antiarrhythmics, should be initiated in the hospital. The use of flecainide is not recommended in patients with less severe ventricular arrhythmias even if the patients are symptomatic.

Because of the proarrhythmic effects of flecainide, its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment outweigh the risks.

Flecainide should not be used in patients with recent myocardial infarction (see Boxed WARNINGS ).

Use of flecainide in chronic atrial fibrillation has not been adequately studied and is not recommended (see Boxed WARNINGS ).

As is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of flecainide favorably affects survival or the incidence of sudden death.

From the FDA-approved label on DailyMed (published Aug 17, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows BPL027 and the other side has only a score line.
  • It is white, capsule, 14 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Flecainide Acetate

Inactive: Magnesium Stearate, Microcrystalline Cellulose, Croscarmellose Sodium, Starch, Corn

Also distributed by

Unichem Pharmaceuticals (Usa), Inc., Pd-Rx Pharmaceuticals, Inc.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Flecainide Acetate pills